http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03035109-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ac9c26d5be7b8229413c74f1956bf91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b5aeda80ceba0a2ab3a2f9c190bc1e9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2c09b40570f696534a8906e95ef6c4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00072393be9faa1dfb82b381386545a
publicationDate 2003-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03035109-A1
titleOfInvention Remedies for pruritus
abstract It is intended to find out a novel pharmacological effect (medicinal use) of cannabinoid. Because of having an excellent antipruritic effect, cannabinoid agonists such as palmidrol and anandamide are useful as remedies for pruritus of any types such as ocular pruritus, skin pruritus and systemic pruritus.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005026138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005026138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7482339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1863784-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2130820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4702840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008032764-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008029825-A1
priorityDate 2001-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0021530-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9903457-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128129271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128484738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427652

Total number of triples: 45.